SBLOF (Shin Nippon Biomedical Laboratories) 3-Year ROIIC % : -4.64% (As of Mar. 2026)


SBLOF Shin Nippon Biomedical Laboratories Ltd SBLOF
74 GF Score
Price $9.16
GF Value $14.04
! 5 Warning Signs
View Full Analysis

What is Shin Nippon Biomedical Laboratories 3-Year ROIIC %?

Shin Nippon Biomedical Laboratories SBLOF -2.13% 74 3-Year ROIIC % is -4.64 as of Mar. 2026. GuruFocus rates SBLOF with a GF Score™ of 74/100 and a GF Value™ of $14.04. The stock has 5 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Shin Nippon Biomedical Laboratories ranks worse than 57.64% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Shin Nippon Biomedical Laboratories's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was -4.64%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Shin Nippon Biomedical Laboratories's 3-Year ROIIC % or its related term are showing as below:

SBLOF's 3-Year ROIIC % is ranked worse than
57.64% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs SBLOF: -4.64

Shin Nippon Biomedical Laboratories  (OTCPK:SBLOF) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Shin Nippon Biomedical Laboratories 3-Year ROIIC % Related Terms


Shin Nippon Biomedical Laboratories 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for Shin Nippon Biomedical Laboratories's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories 3-Year ROIIC % Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -11.57 15.02 3.17 -2.50 -4.64

Shin Nippon Biomedical Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.50 0.00 0.00 0.00 -4.64

SBLOF vs TMO, DHR, IDXX: 3-Year ROIIC % Comparison

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories 3-Year ROIIC % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's 3-Year ROIIC % falls into.


SBLOF
74GF Score
Shin Nippon Biomedical Laboratories Ltd SBLOF
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shin Nippon Biomedical Laboratories 3-Year ROIIC % Calculation

Shin Nippon Biomedical Laboratories's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 12.139005 (Mar. 2026) - 30.6009116 (Mar. 2023) )/( 630.309 (Mar. 2026) - 398.991 (Mar. 2023) )
=-18.4619066/231.318
=-7.98%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of -4.64 mean?
Shin Nippon Biomedical Laboratories (SBLOF) has a 3-Year ROIIC % of -4.64 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shin Nippon Biomedical Laboratories and its competitors. According to the industry distribution chart, Shin Nippon Biomedical Laboratories ranks #117 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 57.6%.
Is Shin Nippon Biomedical Laboratories' 3-Year ROIIC % too high?
Shin Nippon Biomedical Laboratories' current 3-Year ROIIC % is -4.64. Based on the distribution chart, Shin Nippon Biomedical Laboratories ranks #117 out of 203 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Shin Nippon Biomedical Laboratories has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Shin Nippon Biomedical Laboratories' 3-Year ROIIC % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shin Nippon Biomedical Laboratories ranks #117 out of 203 companies for 3-Year ROIIC %. This places Shin Nippon Biomedical Laboratories in the lower half of its industry. The industry median 3-Year ROIIC % is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Diagnostics & Research company?
The median 3-Year ROIIC % among Medical Diagnostics & Research companies is 0.22, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Shin Nippon Biomedical Laboratories and its competitors. For the Medical Diagnostics & Research industry, the median 3-Year ROIIC % is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shin Nippon Biomedical Laboratories's current 3-Year ROIIC % is -4.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shin Nippon Biomedical Laboratories stock overvalued right now?
Shin Nippon Biomedical Laboratories (SBLOF) has a current 3-Year ROIIC % of -4.64. The stock's GF Value™ is $14.04, compared to a current price of $9.16 — trading 34.8% below its estimated fair value. The current 3-Year ROIIC % is -4.64. Shin Nippon Biomedical Laboratories' overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Shin Nippon Biomedical Laboratories (SBLOF), the current 3-Year ROIIC % is -4.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shin Nippon Biomedical Laboratories (SBLOF) Overvalued in 2026?

Based on GuruFocus' analysis, Shin Nippon Biomedical Laboratories stock appears to be undervalued. The current stock price of $9.16 is trading 34.8% below its estimated GF Value™ of $14.04.

Key valuation signals for SBLOF:

  • 3-Year ROIIC %: -4.64
  • GF Value™: $14.04 vs. price of $9.16 (34.8% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SBLOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shin Nippon Biomedical Laboratories Business Description

Other Exchanges 2395:JapanYB3:Germany
Address 8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
74GF Score

Get the complete analysis for SBLOF

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.16
Price
$14.04
GF Value